Grant Bogle
Chief Executive Officer at EPIZYME, INC.
Profile
Grant C.
Bogle is currently the President, Chief Executive Officer & Director at Epizyme, Inc. He is also a Director at Gladius Therapeutics, Inc. Previously, he held positions as a Principal at EIDP, Inc., Senior Vice President-Sales & Marketing at Millennium Pharmaceuticals, Inc., EVP-Strategy & Emerging Businesses at US Oncology, Inc., and Principal at Roche Pharmaceuticals, Inc. He also served as the Executive VP-Integrated Oncology Solutions at US Oncology Holdings, Inc. From 2015 to 2019, he was the Chief Commercial Officer & Senior Vice President at Tesaro, Inc. Additionally, he held positions as a Principal at Abbott India Ltd.
and American Hospital Supply Corp., as well as Senior VP-Pharmaceutical & Biotech Solutions at McKesson Specialty Health, Inc. Mr. Bogle holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Dartmouth College.
Grant Bogle active positions
| Companies | Position | Start |
|---|---|---|
| EPIZYME, INC. | Chief Executive Officer | 2021-08-08 |
| Gladius Therapeutics, Inc. | Director/Board Member | - |
Former positions of Grant Bogle
| Companies | Position | End |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 2019-01-21 |
McKesson Specialty Health, Inc.
 McKesson Specialty Health, Inc. Medical/Nursing ServicesHealth Services McKesson Specialty Health, Inc. provides health care services. It serves the oncologists, rheumatologists and other specialty physicians, pharmaceutical and biotech manufacturers and payers. The company is headquartered in The Woodlands, TX. | Corporate Officer/Principal | - |
| American Hospital Supply Corp. | Corporate Officer/Principal | - |
US Oncology Holdings, Inc.
 US Oncology Holdings, Inc. Medical/Nursing ServicesHealth Services US Oncology Holdings, Inc. operates as a holding company, which offers medical oncology services, cancer center services, pharmaceutical services, and research services. The firm provides comprehensive practice management services for the non-clinical aspects of practice management to affiliated practices in its medical oncology and cancer center services segments. Its healthcare Informatics business collects and analyzes data to provide significant insight into drug performance and patient outcomes for ongoing product development and evaluation. The company was founded in March 2004 and is headquartered in The Woodlands, TX. | Corporate Officer/Principal | - |
| E I DU PONT DE NEMOURS AND CO | Corporate Officer/Principal | - |
Training of Grant Bogle
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Dartmouth College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ABBOTT INDIA LIMITED | Health Technology |
| Private companies | 10 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
US Oncology, Inc.
 US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | Health Services |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
US Oncology Holdings, Inc.
US Oncology Holdings, Inc. Medical/Nursing ServicesHealth Services US Oncology Holdings, Inc. operates as a holding company, which offers medical oncology services, cancer center services, pharmaceutical services, and research services. The firm provides comprehensive practice management services for the non-clinical aspects of practice management to affiliated practices in its medical oncology and cancer center services segments. Its healthcare Informatics business collects and analyzes data to provide significant insight into drug performance and patient outcomes for ongoing product development and evaluation. The company was founded in March 2004 and is headquartered in The Woodlands, TX. | Health Services |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
| American Hospital Supply Corp. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
McKesson Specialty Health, Inc.
McKesson Specialty Health, Inc. Medical/Nursing ServicesHealth Services McKesson Specialty Health, Inc. provides health care services. It serves the oncologists, rheumatologists and other specialty physicians, pharmaceutical and biotech manufacturers and payers. The company is headquartered in The Woodlands, TX. | Health Services |
| Gladius Therapeutics, Inc. |
- Stock Market
- Insiders
- Grant Bogle
